Results 81 to 90 of about 9,620 (164)

Acute Myocarditis: From Pathophysiology to Risk‐Stratified Management—A Clinical Review

European Journal of Clinical Investigation, Volume 56, Issue 8, August 2026.
Stepwise approach to patients with suspected acute myocarditis, integrating the 2024 American College of Cardiology (ACC) four‐stage classification (Stages A–D) and the 2025 European Society of Cardiology (ESC) inflammatory myopericardial syndrome (IMPS) framework. Step 1 (Initial Assessment): clinical presentation, first‐line investigations (ECG, high‐
Michele Golino, Marco Giuseppe Del Buono, Michele Marchetta, Nicola Potere, Aldo Bonaventura, Alessandra Vecchiè, Danilo Malandrino, Giacomo Emmi, Jordana Kron, Antonio Abbate   +9 more
wiley   +1 more source

The changing epidemiology of human type 2 diabetes–associated atherosclerosis: Pathophysiological mechanisms and emerging treatment possibilities

Journal of Internal Medicine, Volume 300, Issue 2, Page 131-152, August 2026.
Abstract Type 2 diabetes (T2D) is a major global health concern strongly associated with atherosclerosis and subsequent macrovascular complications. These complications are the leading cause of death among T2D patients. Despite a decline in cardiovascular events over the last decade, individuals with T2D still have an approximately doubled risk ...
Dania Al‐Sharify, Jiangming Sun, Andreas Edsfeldt   +2 more
wiley   +1 more source

Canakinumab for Atherosclerotic Disease [PDF]

New England Journal of Medicine, 2018
Rothman, A.M., Morton, A., Crossman, D.
openaire   +11 more sources

Efficacy and Safety of Canakinumab Compared With Standard Therapy for the Treatment of Non‐Small Cell Lung Cancer (NSCLC): A Systematic Review

Cancer Reports
Background Lung cancer remains a leading cause of cancer‐related mortality worldwide, with few effective treatment options available for advanced stages.
Kamiar Izadpanah, Masoud Rezaei, Seyed Aria Nejadghaderi, Hamid Sharifi   +3 more
doaj   +1 more source

Association between canakinumab dose and long-term remission in Still’s disease: insights from the AIDA network registry

Frontiers in Pharmacology
ObjectiveThe primary aim of this study was to assess, in Still’s disease, whether the employment of canakinumab at a strictly on-label dose may increase the likelihood of treatment discontinuation due to study-defined long-term remission (LTR), compared ...
Antonio Vitale, Antonio Vitale, Valeria Caggiano, Valeria Caggiano, Jessica Sbalchiero, Jessica Sbalchiero, Giuseppe Lopalco, Abdurrahman Tufan, Gaafar Ragab, Petros P. Sfikakis, Lorenzo Dagna, Lorenzo Dagna, Ezgi Deniz Batu, Seza Ozen, Fabrizio Conti, Federica Maiolini, Serena Bugatti, Micol Frassi, Piero Ruscitti, Maria Morrone, Francesco La Torre, Ibrahim Yahya Cakir, Nergis Akay, Elif Kilic Konte, Katerina Laskari, Yelda Bilginer, Angelica Gattamelata, Jacopo Croce, Ludovico De Stefano, Giulia Voltarel, Paola Cipriani, Maria Cristina Maggio, Sulaiman M. Al-Mayouf, Lampros Fotis, Donato Rigante, Donato Rigante, Jurgen Sota, Jurgen Sota, Elena Verrecchia, Elena Verrecchia, Giuliana Guggino, Lidia La Barbera, Matteo Piga, Giacomo Emmi, Giacomo Emmi, Romina Gallizzi, Giovanni Conti, Paolo Sfriso, Elena Bartoloni, Roberto Giacomelli, Roberto Giacomelli, Patrizia Barone, Alma Nunzia Olivieri, Annachiara Alemanno, Annachiara Alemanno, Alberto Lo Gullo, Haner Direskeneli, Fatma Alibaz-Oner, Anastasios Karamanakos, Marcella Prete, Amr Edrees, Francesco Gavioli, Francesco Gavioli, Paola Parronchi, Francesco Ciccia, Chiara Cardamone, José Hernández-Rodríguez, Gülen Hatemi, Gülen Hatemi, Cemal Bes, Ibrahim A. Almaghlouth, Ibrahim A. Almaghlouth, Ángel Robles Marhuenda, Andrés Gonzáles-García, Carla Gaggiano, Carla Gaggiano, Amato De Paulis, Mehmet Engin Tezcan, Antonio Luca Brucato, Eugen Feist, Eugen Feist, Fernando Tornero-Romero, Benoit Suzon, Benson Ogunjimi, Benson Ogunjimi, Benson Ogunjimi, Benson Ogunjimi, Maissa Thabet, Alessandro Conforti, Valentina Pucino, Oksana Boyarchuk, Tetiana Kovalchuk, Marcello Govoni, Annamaria Iagnocco, Maria Sole Chimenti, Abdelhfeez Moshrif, Emanuela Del Giudice, Francesco Carubbi, Şükran Erten, Samar Tharwat, Samar Tharwat, Mohamed Tharwat Hegazy, Mohamed Tharwat Hegazy, Ewa Więsik-Szewczyk, Jiram Torres-Ruiz, Eduardo Martín-Nares, Albert Balistreri, Albert Balistreri, Claudia Fabiani, Claudia Fabiani, Bruno Frediani, Bruno Frediani, Andrea Hinojosa-Azaola, Özgür Kasapçopur, Luca Cantarini, Luca Cantarini   +115 more
doaj   +1 more source

Treatment of systemic-onset juvenile arthritis with canakinumab

Open Access Rheumatology: Research and Reviews, 2015
Joachim Peitz, Gerd Horneff Pediatric Rheumatology Centre, Department of General Pediatrics and Neonatology, Asklepios Clinic, Sankt Augustin, Germany Abstract: Treatment of systemic-onset juvenile idiopathic arthritis is challenging, but the ...
Peitz J, Horneff G
doaj  

Schnitzler Syndrome as an Autoinflammatory Disease Driven by B‐Cell‐Specific Somatic MYD88 Mutation

Allergy, Volume 81, Issue 8, Page 2969-2971, August 2026.
Yuyi Zhou, Yoko Ueki, Naoya Iwata, Hiroshi Oue, Kentaro Kato, Mengyan Li, Kazushi Izawa, Tomoyasu Jo, Seishi Ogawa, Kenji Kabashima, Naotomo Kambe   +10 more
wiley   +1 more source

Additional Benefit of Canakinumab on Proteinuria in a Case With Muckle-Wells Syndrome in Remission Under Anakinra

The Turkish Journal of Gastroenterology, 2020
We previously reported a case of amyloidosis secondary to Muckle-Wells syndrome (MWS).[1] Briefly, it was a 26-year-old female patient with periodic fever, nephrotic syndrome and sensorineural hearing loss.
Ufuk İLGEN, Orhan KÜÇÜKŞAHİN
doaj  

Functional stratification of MEFV variants by flow cytometric assessment of pyrin inflammasome activation

Pediatric Allergy and Immunology, Volume 37, Issue 8, August 2026.
Blandine Monjarret, Isabel Fernandez, Marie‐Paule Morin, Roxane Labrosse, Kathryn Samaan, Julie Barsalou, Karine Leveillé, Cloé Martin, Aymeric Fabié, Guilhem Cros, Elie Haddad, Jean‐Jacques De Bruycker, Fabien Touzot   +12 more
wiley   +1 more source

Age-Dependent Differences in Canakinumab Safety: A Comprehensive Pharmacovigilance Analysis Using the FAERS Database. [PDF]

Pharmacol Res Perspect
Wang Y, Lam N, Huang X, Jiao Y.
europepmc   +1 more source